Outside Publication

UK Biopharma and Life After Brexit, PharmaLive

September 19, 2016

It may come as no surprise that a pre-referendum ‘Brexit” poll conducted by the UK Pharmaceutical Directors Club of senior management within the UK pharmaceutical industry resulted in a vast majority in favour of “Remain” with local management and head offices concerned about the possibility of the UK exiting the European Union (EU) and negative implications for their businesses.

Read the full article on PharmaLive >>